Drug Database · Clinicians

Latanoprost + Timolol

Brands (5) Xalanol, Astimol, Latochek-T…Show all

Anti-glaucoma; Antiglaucoma preparation and miotic (prostaglandin analogue/Beta blocking agent) PH FDA category
Fixed-dose combination.

Rx · Prescription drug6 PH productsPNF-listed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: XALATAN is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. US FDA label

  • Use: INDICATIONS AND USAGE TIMOPTIC Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Per ml ophthalmic solution: 50 mcg/5 mg
  • Per ml: 50 mcg/5 mg

Registered products in the Philippines

6 products registered with the Food and Drug Administration (FDA) Philippines list Latanoprost + Timolol as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products6
Philippine FDA-registered products for Latanoprost + Timolol
Package insert
AstimolLatanoprost + Timolol (as maleate)
50 mcg / 5 mg per mL Ophthalmic SolutionIn 5 mL White LDPE Bottle x 2.5 mL with dropper-undercap cap (Box of 1's)
Rx
Rafarm SAGreece
Aspen Philippines Inc.Trader: NTC SRL
DR-XY45555
Dec 8, 2031
Latochek-TLatanoprost + Timolol (as maleate)
50 mcg/5 mg per mL Ophthalmic Solution (Eye Drops)2.5 mL in 5 mL-capacity LDPE bottle with white HDPE cap (Box of 1’s)
Rx
Indoco Remedies LimitedIndia
Ambica International Corporation
DRP-8943
Jul 6, 2030
Ocupres PlusLatanoprost Timolol (as maleate)
50 mcg/ 5mg per mL Ophthalmic Solution5 mL-Net Capcity White LDPE bottle with White LDPE dropper-undercap and White LDPE cap x 2.5 mL (Box of 1's)
Rx
Rafarm SAGreece
Unilab, Inc.
DRP-16809
Jul 15, 2030
XalacomLatanoprost + Timolol (as maleate)
50 mcg/ 5 mg per mL Ophthalmic Solution2. 5 mL LDPE Plastic Bottle (Box of 1's)
Rx
Pfizer Manufacturing Belgium NVBelgium
Importer: Viatris, Inc.
DRP-3382
Dec 5, 2029
XalanolLatanoprost + Timolol (as maleate)
50 mcg/5 mg per ml (0.005% / 0.5%)
Rx
Beximco Pharmaceuticals Ltd
—
DR-XY45748
Jan 16, 2027
XalanolLatanoprost + Timolol (as maleate)
50 mcg/5 mg per ml (0.005%/ 0.5%) Ophthalmic Solution (Eye Drops)LDPE Plastic Container and Dropper with HDPE Cap x 2.5 mL (Box of 1’s)
Rx
Beximco Pharmaceuticals Ltd.Bangladesh
I-Senz Medical IncImporter: Ambica International Corporation
DRP-11166
Jan 16, 2032

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Formulary and coverage

Philippine National FormularyListed as Latanoporst + Timolol maleate
PNF listingOpthalmic Solution: 50 mcg + 5 mg/mL, 5 mL bottle
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  2. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .